http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-20170034-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71f918d276f9109d2d6b6b591948b56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87cee01bf4f0223ab433b09675ed7d63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf4c926a0256b6c0ccb22fd8c838678e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f613207dc8c4af5fd03c6947ecc66c2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ba0916be8651a087cd66972263315a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d23fe2a6bbf3e3ed6d8ec4f87ca56b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4014ff5b31cfdc32b0d550376ba6a5e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f24af938abcbe3da835238bd98aecb28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1322b8d0223fef764de07a012436ab91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9579d0801653c8fc487f1cdd2bdcae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15baa778c08999b75794a705c532f313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31551e96d87b49f57a2de3c06c941735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd9cfed139db5cf7e168dc6f03822fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df7899e19ac127e9cc127af6201a089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf820c9aff57e21e38cd7400f8bd067d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32dec112a647f1cc787ef8f82a5a576c
publicationDate 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-20170034-A
titleOfInvention 2- (MORFOLIN-4-IL) -1,7-NAFTIRIDINS
abstract Substituted 2- (morpholin-4-yl) -1,7-naphthyridine compounds of the general formula (I) or (Ib), methods of preparing said compounds, intermediates useful for preparing said compounds, pharmaceutical compositions and combinations which they comprise said compounds and the use of said compounds in the preparation of a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as the sole agent or in combination with other active ingredients.
priorityDate 2014-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432571827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118869290

Total number of triples: 43.